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Adherence to treatment in asthma is often poor, particularly in adolescents and children where the
condition is most prevalent. Electronic monitoring devices have shown potential for improving inhaler
use, yet little research has considered the attitudes of patients towards these devices. We gave seven
adolescents with asthma an electronic monitoring device to use for one month and collected their views
on important issues including monitoring and data sharing. Our results showed that participants felt
positively about using the data to demonstrate responsibility for their condition to both their parents and
medical professionals, but expressed concern for the attention the device’s appearance could draw to
them and their asthma. This paper considers the positive and negative perceptions of this novel device
and provides new insight into the attitudes of adolescents towards inhaler monitoring, as well as future
directions for design and development of monitoring devices for asthma and other chronic medical
conditions.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
1.1. Asthma and non-adherence
Asthma is a chronic inﬂammatory condition of the airways that
affects roughly 5.5 million people in the UK (NRAD, 2014). Although
highly treatable, asthma poses a signiﬁcant economic burden,
costing the NHS £1 billion every year (NHS Information Centre.,
2010).
Asthma inhalers come in two main forms. A ‘rescue’ inhaler is
used to rapidly but temporarily relieve severe symptoms and at-
tacks, whereas a ‘preventer’ inhaler containing corticosteroids is
used daily to suppress airway inﬂammation and keep symptoms
under control (Petrie et al., 2012).
In healthcare, adherence denotes the extent to which a patient
follows a treatment plan that has been prescribed to them by a
healthcare professional (Bender et al., 1997). A robust ﬁnding in. Howard).
r Ltd. This is an open access articlasthma literature is that adherence to inhaled corticosteroids is
sub-optimal (Bender et al., 1997; Lasmar et al., 2009; Milgrom et al.,
1996) with rates ranging from30 to 70% (Horne, 2006). For effective
asthma control and thus reduced emergency room visits and
healthcare costs, a patient should adhere to at least 80% of their
daily medication (Lasmar et al., 2009).
If a patient does not adhere they may experience severe
symptoms and become over-reliant on their rescue medication
(Tan et al., 2009). The impact of overuse of rescue medication was
demonstrated by a study that found a strong correlation between
their increased use and an increased risk of asthma mortality
(Suissa et al., 1994). A recent review of asthma deaths in the UK
further supported this, showing an association between overuse of
short-acting beta agonists (SABA) and asthma deaths (NRAD, 2014).
The importance of adherence to inhaled corticosteroids (preventer
therapy) has also been highlighted, with a strong correlation found
for their proper use and a decreased risk of asthma mortality
(Suissa et al., 2000).e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Adolescents, or young people between the ages of 10 and 19
(World Health Organisation, 2015), are an age group associated
with reduced medical supervision from parents and caregivers as
well as poor adherence to medication (Shah et al., 2001). Focusing
health research on this age group is particularly important as health
behaviours developed here often continue into adulthood and can
have long-term effects on health in later life (Holmbeck, 2002;
Viner and Macfarlane, 2005).
Asthma is one of the most prevalent conditions in children and
young adults worldwide (Michaud et al., 2007). For asthma patients
of 18 years and below, it has been demonstrated that median
adherence rates to inhaled corticosteroid therapy typically range
from 30% to 70% (Klok et al., 2015).
Currently, medical devices with relevance to adolescents are
often designed speciﬁcally for children, or designed primarily for
children but still used by adults (Geljins et al., 2005). It is rarely the
case that adolescents are directly considered and involved in the
design of devices, although notable examples of where they have
do exist (Lang et al., 2012).
1.3. Involving users in the design of medical devices
With the vast number of potential individuals who could
interact with any one device such as patients, doctors, nurses and
familymembers, user needs should be taken into account wherever
possible, as failure to do so makes the device vulnerable to failure
(Grocott et al., 2007).
Whilst involving users may appear unattractive to companies in
terms of added time and cost, the beneﬁts are likely to outweigh
this through successful design that effectively meets the needs of
users, therefore providing an edge over competitors who may not
have been as thorough in their development of device re-
quirements (Martin et al., 2008; Privitera and Murray, 2009).
There are a number of case studies where use of human factors
methods has led to the design of usable medical devices. For
example, interviewing physicians and other end-users and
observing their short-comings led to the successful design of
automated external deﬁbrillators (AEDs) that could be used by
people with no previous experience in emergency situations (Kroll
et al., 1991). Focus groups and usability tests helped to inform a
redesign of infusion pumps, to reduce handling issues as well as
error resistance (Garmer et al., 2002; Liljegren et al., 2000). In
mental health, multiple methods including usability question-
naires, follow-up interviews and a user-trial were implemented in
the development of a personal monitoring system for patients with
bi-polar (Bardram et al., 2013).
The value in considering the design of medical devices is high-
lighted further in Sharples et al., where ﬁve case studies are used to
demonstrate the relationship between medical device design and
resultant user behaviour within a systems context (Sharples et al.,
2012).
1.4. Electronic monitoring devices for asthma
Inhaler use can be monitored through methods including pa-
tient self-report, dose-counting, canister weighing and pharmacy
records, however all of these techniques suffer from inaccuracy
(Howard et al., 2014).
Electronic monitoring devices (EMDs) form a growing area of
asthma research, where it has been demonstrated that they offer
the most accurate solution for monitoring adherence to asthma
therapy (Bender et al., 2000; Burgess et al., 2008; Ingerski et al.,
2011). There is also evidence that these devices can actuallyimprove adherence when they include a reminder function to alert
a patient when their next dose is due (Chan et al., 2015; Charles
et al., 2007).
EMDs usually attach to a patient’s normal inhaler and record a
date and time log whenever the patient actuates a new dose (Chan
et al., 2013). These data have potential to be shared, allowing
stakeholders such as parents, carers, asthma nurses, prescribing
consultants or the patient themself to view data and track inhaler
use over time. Despite robust evidence for their effectiveness in
clinical research for accurately monitoring inhaler use, little to no
research has considered patient attitudes towards these devices
(Howard et al., 2014).1.5. The ‘Internet of Things’ and the trend towards data-driven
healthcare
EMDs for asthma are part of an emerging ﬁeld of devices and
technologies that sit within the ‘Internet of Things’. The Internet of
Things refers to ‘smart objects’ that have at least basic computing
capabilities as well as a connection to other Internet enabled en-
tities (Miorandi et al., 2012). A key feature of these ‘objects’ is their
functionality to sense physical phenomena such as light or tem-
perature, and this is what separates them from normal parts in
typical networked systems (Miorandi et al., 2012).
EMDs are part of the ‘Internet of Things’ as they collect data
about a patient’s inhaler use and transfer this information to an
online database where it can be viewed on a device such as a
smartphone, tablet or computer.
The Internet of Things has great potential for healthcare as it
helps create a shift from cure to prevention (Walport, 2014). Con-
nected devices capable of monitoring a patient’s vital signs such as
heart rate, blood ﬂow and blood sugar can create a wealth of data
collected outside of a patient’s clinical check-ups, allowing for a
much greater understanding of that patient’s health on a day-to-
day basis (Topol, 2012).
For common chronic conditions such as asthma or diabetes,
these smart devices could also potentially allow a clinician to
remotely monitor a patient in near to real time and provide rapid
interventions when signs point to potentially health-threatening
situations such as an oncoming asthma attack. Previous research
has indicated that remote monitoring of patients with asthma
could help to improve treatment outcomes (Steel et al., 2002).1.6. Goals of the study
With adolescence associated with a high asthma prevalence,
poor adherence and a tendency to be overlooked in medical device
design (Geljins et al., 2005; Lang et al., 2012), this study aimed to
investigate the potential impact of an exemplar EMD called the
‘SmartTrack’ on a sample of adolescents with asthma. The Smart-
Track device monitors and records the exact date and time of every
inhaler actuation and can upload this information to an online
database where it can be viewed by anyone with granted access.
Audible tones can also be played to remind the patient when their
next dose is due.
This paper provides new insight into the attitudes of adolescent
users towards the concept of a ‘smart inhaler’, with particular focus
on feelings about having their medication-taking behaviour
recorded, and the extent to which they would be comfortable with
this recorded behaviour being shared. This research determines
future directions for the design and implementation of smart in-
halers speciﬁcally, and technology-enhanced medical devices more
generally.
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A sample of seven adolescents with asthma used a SmartTrack
device for a month with their normal preventer inhaler. Over this
time, they met with the researcher on three occasions, completing
an interview and questionnaire each time.2.1. The ‘SmartTrack’ smart inhaler
The SmartTrack device (see Fig 1) clips around a patients normal
MDI. The main components of the device are its visual display that
can show information about when the last dose was taken, battery
level and time (Chan et al., 2013). Four black buttons surround the
display and can be used to navigate through the device’s settings,
allowing the user to set up reminder tones to play when their next
dose is due, select different ringtones or change the date and time
(Howard et al., 2014).
The SmartTrack records the date and time of every actuation
using an optical dose counter (Foster et al., 2012). By connecting the
device to a PC, data on inhaler use can be uploaded to an online
database where the patient or anyone they grant access to can view
patterns of inhaler use over time (Chan et al., 2013). During the trial
participants were given a username and password so they could
view this information from home.2.2. Participant recruitment and sample
All participants were recruited from the Children’s Respiratory
Service at Queens Medical Centre Hospital, Nottingham UK. The
study was advertised through posters on the children’s ward. The
asthma nurse at the respiratory clinic also approached eligible
patients, providing themwith information on the study and asking
if they would be interested in taking part. The respiratory clinic
dealt with secondary care patients (i.e. children with asthma
requiring long-term follow up).
16 participants were approached in total, nine decided not to
take part. Three patients declined due to the distance and fre-
quency of visits that would be required. One patient declined due to
upcoming exams, twomore failed to respond to phone calls and the
remaining three patients simply did not want to participate (one
felt he was too old).
Seven adolescents with asthma took part in the study. Their ages
ranged from 11 to 16 years (mean of 13.4). Five of the participantsFig. 1. A SmartTrack device (black) clipped around a purple standard metered dose
inhaler (MDI) (image included with permission from SmartInhaler, www.smartinhaler.
com). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)were male and two were female. All seven participants used a
seretide MDI and were required to administer two doses twice
daily as part of their typical treatment regime.
Participants were not compensated for their time but could
claim for travel expenses outside of their usual care visits.
A parent for each participant also took part in the study, ﬁlling in
a questionnaire for each of the three clinic visits. For all seven
participants it was their mother who took part in this role.
2.3. Ethics
Full NHS ethical approval was obtained for this study from the
Nottingham Research Ethics Committee 1 (REC ref: 14/EM/0003).
All participants provided their informed consent to take part in
the research, with those under 16 years of age having consent
provided by a parent or guardian, accompanied by the participant’s
own assent.
2.4. Procedure
All approached patients were ﬁrstly given at least 24 h to decide
whether to consent to taking part. A clinic visit was then arranged
with the participant so they could be assigned a SmartTrack device.
During this ﬁrst clinic visit, participants were shown the
SmartTrack device and told how it worked and what it was capable
of doing. The device was then set up to present reminders at times
consistent with the participant’s current treatment plan and play a
ringtone whenever their next dose was due. The researcher ﬁrstly
set up the ringtone reminders, but the participant was then
required to show they understood how the reminder time and tone
could be changed by navigating to these settings on their own.
Both participants and their parent were made fully aware of the
purpose of the SmartTrack device through the initial information
sheet and the subsequent demonstration carried out by the
researcher.
The study consisted of three separate clinic visits. These
occurred in their usual clinic room with the parent sat outside to
reduce any inﬂuence they may have over their child’s answers. A
nurse was always present but sat away from the participant and
was there in case of any medical questions the researcher was
unqualiﬁed to answer.
On all three occasions the participant was required to ﬁll out a
questionnaire and complete a semi-structured interview on their
attitudes towards the SmartTrack device. The details of the ques-
tionnaire and interviews are described below.
2.4.1. Questionnaire
The questionnaire contained 105 statements in total. Partici-
pants were required to select one option for each statement, either
‘strongly agree’, ‘agree’, ‘disagree’ or ‘strongly disagree’. No neutral
option was provided to prevent participants from ‘sitting on the
fence’ about issues directly relevant and important to their own
condition.
The questionnaire design was ﬁrstly based on the Adolescent
Medical Devices Assessment Toolkit (AMDAT) which contains a
range of statements that can be included in an evaluation of
medical devices for this age group (Lang, 2012). Statements rele-
vant to the SmartTrack device were taken from the AMDAT. These
statements fell under the themes; ‘Ease of Use’, ‘Social Acceptance’,
‘Portability and Practicality’ and ‘Aesthetics’. The theme ‘Mainte-
nance’ was not included as the SmartTrack does not require
cleaning. The theme ‘Adherence to regular and correct use’ was not
included as this mostly focuses on technique and ‘proper’ use but
the SmartTrack does not record data on inhalation technique.
As adherence to regular use is central to the function of the
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ence data were added to the questionnaire design; ‘Data Moni-
toring’, ‘Data Sharing’ and ‘Communication and Feedback’.
Questions were formed for these themes based on knowledge of
the SmartTrack device and its capabilities and followed the format
of the statements taken from the AMDAT. The statements used in
the questionnaires can be found in the Appendix.
Seven themes were used in the questionnaire. The question-
naire was divided into three different parts which were adminis-
tered in three separate meetings with the participants. The
questionnaire was split into shorter, more manageable chunks as
time with each participant was limited. Each of the three parts
included ﬁve different statements per theme and so 35 statements
overall. Across all three parts of the questionnaire there were 15
different statements per theme in total. An example of a statement
for each theme can be viewed in Table 1.
A parent for each participant was also required to ﬁll out a
questionnaire at each of the three clinic visits. This was the same
questionnaire, but the statements were framed to investigate what
parents thought their child’s attitudes would be, for example “I
thinkmy child would think the information on the devices screen is
easy to read”. This was to create comparison between participant
attitudes and perceived attitudes from their parents.2.4.2. Interviews
Interviews ranged from 5 to 31 min in length (average of
15:05min) and an overall total of 5 h and 24min of interviewswere
recorded. Although parents were not interviewed, they were
encouraged to write comments at the end of their questionnaires.
The participant interviews were guided by a schedule contain-
ing a set of open-ended questions, with some being followed up
with prompts for more speciﬁc information if the participant was
providing short answers. The questions focused on similar topics to
the questionnaire, such as device appearance, monitoring capabil-
ities and the merits of sharing inhaler use data.
At the ﬁrst and third clinic visit, participants were questioned on
their experiences with the Smart Inhaler. However, for the second
clinic visit the interview focused speciﬁcally on alternative
methods formonitoring their inhaler use such as dose counting and
canister weighing.
These alternative methods were ﬁrstly explained to participants
using a set of vignettes. Five vignettes were used, with each
covering a different method of monitoring, namely: patient self-
report; dose counting; canister weighing; pharmacy records; and
electronic monitoring devices (EMDs) such as the SmartTrack. An
example vignette is shown in Fig. 2.
For each method, the researcher used the visual aid of the vi-
gnettes to brieﬂy describe how each one worked. Each method was
then framed for participants in terms of what they would need to
do and what they would get in return. The details for each method
are shown in Table 2.
To aid discussion, participants were asked to rank the ﬁve
methods of monitoring in terms of their personal preference andTable 1
The seven themes of the questionnaire with an example statement for each.
Theme Example statement
Ease of use The information on the dev
Social acceptance I would take this device to
Portability and practicality The device would stay intac
Aesthetics The device feels like it’s a q
Data monitoring I feel happy with the device
Data sharing I would feel happy sharing
Communication and feedback I would like it if I could recthen explain why they had chosen that order. Firstly, they made
their ranking judgement purely on the basis of what they need to
do, then considering what they get in return, and lastly they ranked
them overall.
The rankings were used as a mechanism for getting the partic-
ipants to think critically about what would be best in their own
asthma care; thinking in particular about the effort on their own
part, as well as the potential beneﬁts they could gain from some in
terms of more detailed data, better feedback and ultimately better
asthma management.
2.5. SmartTrack data upload
At the second and third clinic visits, the patients SmartTrack
device was connected to the researcher’s laptop so that data could
be uploaded to the Smart Inhaler online database.
Participants were given a username and password so that they
could logon to the website and view their adherence data if they
wished.
Adherence was not a primary research aim of the study, so this
data was only checked by the researcher to ensure that participants
were not taking a potentially dangerous amount of medication, in
which case the researcher’s clinical supervisor would be alertede a
situation that did not occur.
3. Results
The results of the questionnaire data for both participants and
their parents will be presented ﬁrst, followed by the results of the
interview data, where a thematic analysis was carried out to un-
cover emergent themes.
3.1. Questionnaire results
Fig. 3 shows a graph of the responses from the seven partici-
pants. The equivalent responses from their parents are also shown.
As can be seen from Fig. 3, for all seven themes in both
adolescent participants and their parents, there were noticeably
more positive responses compared to negative. For example, in the
theme of ‘monitoring’ 100 participant responses were positive
(either agree of strongly agree) whereas only 5 were negative
(either disagree or strongly disagree). In comparison, parents’ re-
sponses for questions under this theme yielded 102 positive re-
sponses and only 3 negative ones, none of which were ‘strongly
disagree’.
To investigate the distribution of responses for the seven
themes, Bonferroni corrected Chi-square tests were carried out on
each theme for both participant and parent data. For all seven
themes, participants and parents showed a signiﬁcant preference in
agreement with statements (p < 0.003). The questionnaire results
therefore show clear positivity for participants and parents towards
the SmartTrack device.
To identify any differences between adolescent participant andice’s screen is easy to read
a friend’s house
t and not break if it was dropped on the ﬂoor
uality product
recording my inhaler use
information on my inhaler use collected by this device with my parents/guardians
eive feedback on my inhaler use on a weekly basis
Fig. 2. An example vignette explaining the process of patient self-report in simple terms, framing it for the participant as what they need to do and what they can get in return.
Table 2
Information included in the ﬁve vignettes for the different methods of monitoring.
Methods ‘What you need to do’ ‘What you get in return’
Patient Self Report
(PSR)
Remember when and how often you have been taking
your purple inhaler
Let your doctor or asthma nurse know
Help you to talk to your doctor or nurse about your asthma treatment
Help you to get better treatment if you are taking your purple inhaler and your asthma is still
affecting you
Dose Counting (DC) Bring your inhaler when you come to the clinic Your doctor can know how much medication in total you have used since your last clinic
visit
But will not know any information about exactly when you have been taking it e.g. twice in
the morning, twice in the evening
Pharmacy Records
(PR)
Simply collect a new inhaler from the pharmacy when
you need one, as you usually would.
Same as Dose Counting
Canister Weighing
(CW)
Bring your inhaler when you come to the clinic Same as Dose Counting
Electronic
Monitoring
Device (EMD)
Have a device like the Smart Inhaler attached to your
usual inhaler to carry around with you
Smart Inhaler needs charging occasionally
Smart Inhaler needs to be connected to a PC to upload
information about your inhaler use
Detailed information about exactly when you have been using your inhaler on a daily basis
Can be shown to your parents, your doctor, your nurse etc. so you can talk about your
asthma and asthma treatment and look at ways it could be improved
S. Howard et al. / Applied Ergonomics 58 (2017) 224e237228parent responses, nonparametric Bonferroni corrected Mann-
Whitney U tests were carried out on the two most noticeably var-
ied themes; ‘Communication and Feedback’ and ‘Ease of Use’. It was
found that there was a signiﬁcant difference between adolescent
and parent responses for the theme ‘Communication and Feedback’
(U ¼ 4497.5, n1 ¼ n2 ¼ 105, p < 0.025, two-tailed) and from the
graph in Fig. 3 it can be seen that adolescents had more ‘disagree’
responses (19e6) whilst the parents had more ‘strongly agree’ re-
sponses (25e15), showing that the parents were in greater agree-
ment with statements related to this theme compared to their
children.
Tests showed there was no signiﬁcant difference between ado-
lescents and parents for ‘Ease of Use’ (p > 0.025). However, there
was a tendency for the adolescents to be more critical for this
theme, with 3 ‘strongly disagree’ responses and 21 ‘disagree’ re-
sponses compared to only 1 ‘strongly disagree’ and 8 ‘disagree’ for
the parents (see Fig. 3). This suggests that this may be an important
factor to take into consideration for the adolescents.
Also of note in the data, although not statistically signiﬁcant, is
the larger amount of ‘strongly disagree’ responses from the ado-
lescents (13) for the theme ‘Aesthetics’ compared to the parents (2)(see Fig. 3). This again indicates that this may be an important
factor to take into consideration when designing devices for this
demographic.
Further exploration of the questionnaire data including an in-
spection of speciﬁc questions will be covered in the discussion.
3.2. Interview analysis
A six stage systematic approachwas used to carry out a thematic
analysis on the interview data (Braun and Clarke, 2006). This ﬁrstly
involved a prolonged period of familiarization with the data, fol-
lowed by an initial process of coding the data for basic issues and
factors. Codes were then grouped into an initial set of themes that
were reviewed to check that they appropriately reﬂected the data.
Once the researcher was satisﬁed with the themes produced, their
names and descriptions were determined and a report of the out-
comes of the thematic analysis could be produced (Braun and
Clarke, 2006; Thomson et al., 2013).
Four major themes were identiﬁed through the analysis of the
interview data, these were: ‘Taking control of condition’, ‘Social
compatibility’, ‘Sharing and feedback of adherence data’, and
Fig. 3. A graph showing the total responses from both adolescent participants and their parents for the seven themes of the questionnaire (N ¼ 105, where seven participants gave
ratings for 15 statements per theme).
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major themes, three sub-themes were identiﬁed and these will be
presented in the following sections, with quotes from participants
to support them. Quotes are presented in a separate table for each
theme and then referred to in the text.
3.2.1. Taking control of condition
Participants expressed enthusiasm for utilising the SmartTrack
device to help them take control of their asthma. Subthemes here
were: utilising data for proof of independence, demonstrating re-
sponsibility, and reminders to facilitate better adherence.
3.2.1.1. Utilising data for proof of independence. All seven partici-
pants spoke about how they could use the data produced by the
SmartTrack device to show either their parents or one of their
healthcare providers that they have been taking their inhaler
properly.
The examples in Table 3 (quotes 1a and 1b) demonstrate how
these participants have critically thought about the data produced
by the device and how they could use it to their beneﬁt. The second
quote from Ad4 is particularly interesting as it shows they have
contemplated howproving they are taking their inhalermay lead to
an adjustment to their medication, to make sure it is as effective as
possible for their asthma.
3.2.1.2. Demonstrating responsibility. Throughout the three in-
terviews of the study, participants also consistently demonstratedthat they took responsibility for the management of their asthma.
This was often through talking about why it is important that they
take their inhaler (quote 2a), as well as recognizing the negative
impact that dishonesty about their inhaler use could have on their
health (quote 2b).
3.2.1.3. Reminders to facilitate better adherence. Although a sec-
ondary function of the SmartTrack device, participants were
enthusiastic about the reminders the device could provide and
often spoke about how they helped them to remember to take their
medication (see quotes 3a and 3b).
Perhaps the most interesting part of the enthusiasm for the
reminders was that despite appreciating their helpfulness, many
participants also spoke about how annoying they could be, whilst
still recognising their overall beneﬁt (see quote 3c).
3.2.2. Social compatibility
As opposed to the positivity participants showed for the func-
tionality of the device and its ability to record and remind them
about their inhaler use, there was general concern for the social
acceptability of the device in terms of its appearance. Subthemes
here were: drawing of attention, unwanted questioning and inﬂu-
encing likelihood of use.
3.2.2.1. Drawing of attention. Four participants directly commented
on what their friends or peers may think if they saw themwith the
device; quote 4a in Table 4 was a prime example of this. One
Table 3
Example quotes under the theme ‘Taking Control of Condition’.
Main theme Subtheme Quotes
Taking control of
condition
Utilising data for proof of
independence
1a. “My mum nags me quite a bit about taking my inhaler, so does my Dad. So I think they might stop nagging as much if they
know I’m taking it properly” (Ad7)
1b. “Recording the information so that the doctor can actually see that I’ve been taking it, and if my asthma is not improving
then there’s proof there that it’s the inhaler (at fault) and not me not taking it” (Ad4)
Demonstrating
responsibility
2a. “I don’t want to be having asthma for the rest of my life really, and it could help me get rid of it in a way, and grow out of it”
(Ad2)
2b. “It kind of makes you have to be honest, because if you lie you don’t really get anywhere, and your doctor may think your
asthma is getting better but it’s actually not. So having to be honest, and remembering when you’re taking it I think would be
good” (Ad7) (When discussing Patient Self-Report)
Reminders to facilitate
better adherence
3a. “Teenagers, because they forget. If you didn’t have that to remind you, you’d just wake up and wouldn’t think about it, and
then you’d go to sleep and you wouldn’t think about it and you’d end up forgetting to take it” (Ad4)
3b. “Teenagers because they are starting to live their life, and when they get home will probably forget to take their inhaler, so
it would be nice to have a reminder” (Ad6)
3c. “The ringtone got on my nerves… It’s helped… it’s like you have to do this, if you want to do that, kind of. Like you have to
live with the constant annoyance if you want to be healthy!” (Ad5)
S. Howard et al. / Applied Ergonomics 58 (2017) 224e237230participant related using the SmartTrack device to a previous
experience with a spacer for their inhaler (see quote 4b). This
participant showed particularly concern for the attention the de-
vice may draw to her (see quote 4c), providing an example context
of use where she would be conscious of people staring at her.
3.2.2.2. Unwanted questioning. Two participants went a step
further than simply having concerns about attention alone and
additionally felt that the device could be the cause of unwanted
questions. Quote 5a provides an example of this, where the
participant feels the device’s unusual appearance would lead to
quizzing from friends.
Although unwanted questions were often spoken about as
coming from friends, one participant additionally raised concerns
about the questions that his teachers might have if he were to use
the device in assembly at school (see quote 5b).
3.2.2.3. Inﬂuencing likelihood of use. When contemplating the
attention and questions that the device may create, three partici-
pants commented that this might directly inﬂuence whether they
would use the SmartTrack (see quotes 6a and 6b).
However, one participant had a more relaxed opinion and did
not seem as bothered by what his peers might think. This partici-
pant seemed more of the opinion that it is something he has to do,
so it is better to just get on with it (see quote 6c).
3.2.3. Sharing and feedback of adherence data
When discussing the SmartTrack’s ability to record information
on their inhaler use, participants spoke of the effects that sharing
this information could have as well as the way they would like to
receive feedback on their adherence. Subthemes here were:
Awareness of monitoring; communicating and sharing with others;
and validity of data on inhaler use.
3.2.3.1. Awareness of monitoring. Some of the comments made by
participants indicated that the idea of their parents or doctor
monitoring their inhaler use would have an effect on their medi-
cation taking behaviour (see Table 4, quotes 7a and 7b).
Participants viewed this monitoring as a positive thing, recog-
nising that inhaler use is an important thing to monitor, that the
data will help them to demonstrate that they are taking their
inhaler as recommended, and the people viewing that information
will treat it appropriately (see quotes 7c and 7d).
3.2.3.2. Communicating and sharing with others. Participants spoke
about whom they would share information on their inhaler use
with and why sharing this data might be a good thing. Twoparticipants spoke speciﬁcally about the beneﬁts of sharing infor-
mation through patient self-report (see quote 8a for an example).
One participant showed real consideration for who they would
like to be able to see SmartTrack data on their inhaler use, as well as
whom they would not want to share data with (see quote 8b). This
demonstrates a level of critical decision-making where the partic-
ipant has considered the dangers or negative implications that
being too open with their information could have.
Another participant spoke about the way in which they would
ideally like to communicate and share adherence data with their
doctor, suggesting that a smartphone application would be an
effective way to view and send data on their inhaler use (see quote
8c).
3.2.3.3. Validity of data on inhaler use. In the second interviews
participants mainly discussed alternative methods of measuring
adherence, comments suggested that participants understood how
the validity of the data collected by these different methods varied.
When discussing patient self-report, one participant talked
about the beneﬁt of speaking to your doctor or nurse, but
acknowledged that relying on the patient to recall inhaler use may
not be the most accurate method (see quote 9a). The same partic-
ipant then additionally commented on the improved accuracy of
the dose count an EMD records compared to typical dose counting
on a standard MDI (see quote 9b).
3.2.4. Practical improvement for more effective use
Participants provided suggestions and recommendations for
how the SmartTrack device could be improved to more effectively
meet their needs. Subthemes here were; better reminders, device
aesthetics and usability.
3.2.4.1. Better reminders. Although participants spoke of the use-
fulness of the reminders for helping them take their inhaler more
often, many believed the ringtones could be improved by including
the ability to use your own music or tones (see Table 6, quote 10a).
However, not all participants felt they would like the ability to
put their own ringtones on the device. One participant felt this
might be too complicated and would prefer a pre-loaded list to be
able to select from. They also felt that the tones should be loud and
of sufﬁcient duration for you to be locate the device if you have
misplaced it somewhere in the house (see quote 10b).
3.2.4.2. Device aesthetics. Often alongside discussing what their
friends and peers might think of the device, participants expressed
opinions on the SmartTrack’s appearance and how it could be
improved. This largely focused on reducing the size of the device as
Table 4
Example quotes under the theme ‘Social Compatibility’.
Main theme Subtheme Quotes
Social compatibility Drawing of attention 4a.“They’ll probably take the mick. They’ll think I have really bad
disabilities, they’ll think I’ve just got problems … If people had a problem
with me, maybe the thing they’d get me with is that. But my friends
wouldn’t take the mick, they’d probably think it’s cool” (Ad5)
4b.“At primary school when I had the spacer for my inhaler, everyone used
to stare at me. So it would probably be the same thing” (Ad6)
4c.“Because sometimes I need to carry it outside with me, because
sometimes I get really wheezy during PE so I need to take it. Andwhen I take
it out people always stare at me. So they’ll stare at me even more with that”
(Ad6)
Unwanted questioning 5a.“I just wouldn’t take it around with them (friends)… they’d ask loads of
questions … You can tell it’s different - not meant to be on there. Everyone
would be like, ’What’s that? What’s that?’” (Ad3)
5b.“In assembly at school when there’s lots of people there. I’m taking it out,
and most people have normal inhalers and I’m pulling this massive thing
out. Even the teachers would be looking at me like ’what’s that?’ There’d be
a lot of questions, especially the teachers, because they would want to know
what it is and everything” (Ad5)
Inﬂuencing likelihood of use 6a.“I think it might. If you become unpopular with your friends and they
start laughing at you for having something weird clipped around your
inhaler” (Ad7)
6b.“I wouldn’t really be very comfortable with it, some other people who
just have asthma like me just have a normal inhaler, and then I’ve just got
this technical one, which seems a bit awkward” (Ad6)
6c. “They wouldn’t think any different, it’s what I’ve got to do. If I’ve got to
take it, I’ve got to take it. It’s just like a normal inhaler, but with something
on the end of it.” (Ad4)
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3.2.4.3. Usability. Participants also offered suggestions for how the
device could be made easier to use. This often involved the buttons
of the device, or the screen where information is displayed (see
quotes 12a and 12b).
Participants also spoke about how the size of the device could
affect their use of it, with one participant commenting on the
concerns they would have for getting their inhaler out of their bag
rather than their pocket if they were having an asthma attack (see
quote 12c).
There was also an interesting case where the current design of
the device was inﬂuencing the way in which the participant used
their inhaler (see quote 12d). The participant was utilising the ‘time
since last use’ feature on the screen of the device to count the 5 s
between their two puffs. This isn’t a recommended way to take an
inhaler, so future design of the device should look to afford an
upright and typical method of inhalation.
3.2.5. Vignette ranking results
Although the ranking exercise for the vignettes of alternative
ways of monitoring was primarily used as a way to get participants
thinking critically about these methods to aid discussion; the re-
sults of the rankings still offer some indication of participant
preferences.
Participant rankings for each monitoring method were accu-
mulated and the average mode rank for each method was calcu-
lated for ‘what you need to do’, ‘what you get in return’ and
‘overall’.
As can be seen from Table 7, EMD was consistently ranked ﬁrst
across the three different ranking exercises. In fact, EMD was
ranked ﬁrst by all participants across all three ranking exercises,
apart from on one occasion. One of the participants ranked EMD
last for ‘What you need to do’ commenting that the patient actually
hasmore to do for EMD’s compared to the othermethods. However,
they ranked EMD top for ‘What you get in return’ and ‘Overall’,
indicating that the beneﬁts of EMDs outweighed the efforts on theirpart; in terms of carrying the device around with them, charging it
and uploading data.
3.2.6. Parental feedback
Although parents were not interviewed, they were encouraged
to write comments on the back of their questionnaires if they had
any feedback on the SmartTrack device and it’s use in their child’s
asthma. Only four of the parents provided comments (see Table 8),
but all focused on the utility of the device in helping their child to
take their inhaler and keeping a record of adherence.
4. Discussion
The user trial with the SmartTrack device has shown positive
results for the use of this type of technology in the treatment of
asthma for adolescents.
The questionnaire results highlighted a signiﬁcant preference in
agreement with statements for all seven themes for both adoles-
cent participants and their parents. The interview data largely
supported these ﬁndings, with participants expressing enthusiasm
for using this device as a way to prove they can independently
manage their condition responsibly.
4.1. Comparing questionnaire and interview results
4.1.1. ‘Communication and feedback’
The questionnaire results showed a signiﬁcant difference be-
tween adolescent participants and parents for the theme
‘Communication and Feedback’.
The majority of negative responses from the adolescents came
for the statements ‘I would like it if I could receive feedback on my
inhaler use by e-mail’ (four disagreed) and ‘I would like it if I could
receive feedback on my inhaler use by phone call’ (ﬁve disagreed).
In comparison, all parents either agreed or strongly agreed that
they thought their child would like to receive feedback through e-
mail. This therefore highlights where the adolescents’ preferences
for communication methods differ to their parents expectations.
Table 5
Example quotes under the theme ‘Sharing and Feedback of Adherence Data’.
Main theme Subtheme Quotes
Sharing and feedback of
adherence data
Awareness of monitoring 7a.“I’ve felt aware, but I suppose that’s a reason for you to take it as well, because if you haven’t taken it your doctor will
see and then he’ll moan at you, so you’ve got to take it so you don’t get moaned at. So that’s kind of like another
reminder” (Ad4)
7b.“I’m always taking it more, because I know that it’s being monitored so I know I need to take it more” (Ad1)
7c.“Ok because it’s not just like anyone is seeing it, it’s professionals so it’s alright” (Ad1)
7d.“I don’t really mind, because it tells people that I actually use it, so they won’t think any less of me” (Ad6)
Communicating and
sharing with others
8a.“Because you’re talking to your doctor about information then, and you can talk about how you’re feeling as well”
(Ad2)
8b.“I’d share it with my doctors and nurses, parents and guardians,maybe cousins andmaybe if they got used to it, some
really close friends who I know won’t laugh at it … I’ve got a couple of friends who I often fall out with, so I probably
wouldn’t like to share it with them. And strangers, because stranger danger. People who’d laugh at it.” (Ad7)
8c.“It would be good to have a smartphone app. Because then it’s always there, you can do it on the go, you don’t have to
be at home or on your laptop or computer, or at the doctors. Also, if on the app there was a way of sharing, like sort of
messaging, that you could do on it, to send info on your inhaler (use)” (Ad4)
Validity of data on inhaler
use
9a.“It does help you talk to your doctors and nurses about what you’ve been doing, like more conﬁdently. But if they’re
getting it from me, they’re not getting all the information because even though I can keep track, sometimes I’ll probably
forget” (Ad5)
9b.“Yeah, the inhaler already has a count of how many puffs you took, but that keeps a better track, a digital track”
(Ad5)
Table 6
Example quotes under the theme ‘Practical Improvements for More Effective Use’.
Main theme Subtheme Quotes
Practical improvements for more
effective use
Better
reminders
10a.“It would be better if you could plug it into the computer and have your own tune, rather than just the default tune.” (Ad4)
10b.“I think it would be too complicated to put my own on. So I’d like the list, but good ones. It doesn’t have to be a good theme
tune but something that’s loud enough so you can hear it… I want it to be quite long so you can hear it and hear where it is.When
it goes off you spend like half an hour trying to ﬁnd it” (Ad5)
Device
aesthetics
11a.“It’s quite small, but it looks a bit too bulky, it could be a bit thinner. But the colours alright … It would just look better if it
was thinner and not as fat” (Ad4)
11b.“Make it a bit smaller and change the colour … bright colours” (Ad3)
Usability 12a.“At ﬁrst when I ﬁrst saw it I thought it was difﬁcult to use, and then when I got it and was just scrolling through trying to
learn it, it actually became pretty easy. For people with learning difﬁculties I don’t know if they’d be able to use it or not” (Ad5)
12b.“The buttons. They’re just like four normal buttons, they all look the same. They should look a bit different to remind you.”
(Ad6)
12c.“I usually havemy blue inhaler in the side pocket of my blazer, and I don’t think with this around it… I think after it would be
bigger because my blue inhaler is actually quite big… I could put it in my bag, but if I’m having an asthma attack, it’ll take me a
while to get it out my bag” (Ad5)
12d.“I kind of take it on its side so I can see the timer there so I can see how long it’s been, to make sure I’m taking it properly.
Because I have to breathe in and out ﬁve times after I’ve puffed it, and I make sure I do that for 5 s, so I’ve been looking at that…
Yeah I kind of hold it on it’s side now, so I can see the screen and count 1, 2, 3, 4, 5 so I know I’m doing it properly.” (Ad7).
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they would like to receive feedback through a dedicated smart-
phone app. This helps demonstrate that they would like to receive
feedback, but that certain methods would be preferred over others,
meaning that negative responses may be due to preferences over
mode of communication, rather than the concept of sharing data
and receiving feedback. This preference for a smartphone app is
supported in the interview data by the quote from Ad4 stated in
Table 5 (8d).
4.1.2. Other questionnaire statements highlighted as receiving
negative responses
Although there was largely very positive response to nearly all
questionnaire statements, there were statements that received
more negative response. These were inspected further, to identify
why this may have occurred and explore how the interview data
may support it.
For the theme ‘Portability and Practicality’ the statement “It
would be an improvement if the device could ﬁt in a jacket or
trouser pocket” collected ﬁve agrees and one strongly agree from
the participants (these were subsequently reversed to ﬁve dis-
agrees and one strongly disagree during data analysis due to the
negative framing of this statement, as ‘agreement’ with it would be
a negative for the device). This is supported by the interview data.For example, Ad2 stated “Deﬁnitely make it smaller. Just so it could ﬁt
in your pocket better, so there isn’t a massive bulge in your pocket”.
A further example comes from a statement for the theme Aes-
thetics e “The device would beneﬁt from customizable decoration”
which received six agrees and one strongly agree (these were again
reversed to be disagrees for statistical analysis). This can also be
supported by the interview data, for example, Ad5 stated “It could
have accessories, like you know on a phone it has a corner and you can
hang a little keychain off it or something” whilst many of the other
participants commented on how they would like a range of colours
to be available. This additionally explains the response participants
had to another Aesthetics statement, “I think the device would look
better in a different colour.”
4.1.3. Differences between participants
One participant in particular stood out as having lower scores
for statements related to ‘Aesthetics’ (average mode response of 1,
‘strongly disagree’) and ‘Social Acceptance’ (averagemode response
of 2, ‘disagree’) compared to the others. This was again supported
by the interview data, as this participant consistently commented
on the concerns they would have about how their friends would
respond to the devices appearance. For example, they stated “I don’t
think they’d care about the asthma side, they’d just care about how it
looks” as well as “Well some of my friends would be like ’oh it’s so cool’
Table 7
Methods of monitoring ranked according to their mode average.
Mode rank What you need to do What you get in return Overall
1 Electronic Monitoring Device Electronic Monitoring Device Electronic Monitoring Device
2 Patient Self Report Patient Self Report Patient Self Report
3 Dose Counting Dose Counting Dose Counting
4 Canister Weighing Pharmacy Records Canister Weighing
5 Pharmacy Records Canister Weighing Pharmacy Records
Table 8
Comments from four of the parents of the adolescent participants.
Parent Quote
Parent for
Ad1
“Since using the Smart Inhaler *name*’s asthma has improved a great deal.Hewas using his blue inhaler too much before he started to use his Smart Inhaler, now he
is down to taking it 2e3 times a week. A massive improvement.”
Parent for
Ad2
“Excellent innovation and useful re ‘reminder’ option”
“Since using the Smart Inhaler my child’s asthma has noticeably improved and he has not needed his Ventolin as much, if ever. To me this indicates he has taken his
preventive inhaler regularly as the alarm on the Smart Inhaler has reminded him. I have not needed to remind him”
Parent for
Ad4
“This device would be very useful with the blue salbutamol inhaler to see when and how much children are using their inhaler”
Parent for
Ad7
“Every time the smart inhaler’s ringtone goes off, *name* is enthusiastic about going and taking his inhaler.”
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weird.”
Throughout all three interviews, this participant expressed their
concern about the appearance of the device, particularly if they
were to use it in front of their friends or peers. The fact that the
questionnaire data was very well in-line with the opinions brought
out in the interview data highlights the consistency between these
two data sources.
The fact that some participants felt more strongly about the
appearance of the device than others reinforces previous research
withmedical devices for adolescents, where it was found that some
were in preference of ‘customisation’ of the device both in
appearance and auditory reminders, whereas others felt that it is
just a medical device and the appearance should not really matter
(Lang et al., 2014). Enabling personalization of medical devices for
adolescents may be a way of engaging a wide range of teenage
users, as it allows those who care about the devices appearance to
tailor it more to their individual preferences, without disengaging
those who are happy with a more typical medical device with no
customisation.
4.1.4. Overlap between questionnaire and interview themes
It is important to consider where the seven themes of the
questionnaire and the emerging themes from the interview data
overlap. The largest overlap appears with the practical aspects of
the device such as its appearance. The interview data formed
themes such as ‘device appearance’ ‘drawing of attention’ and
‘unwanted questioning’ and these are highly related to the themes
‘aesthetics’ and ‘social acceptance’ in the questionnaire.
However, the theme ‘Taking control of condition’ with its three
subthemes and focus on promoting independence and re-
sponsibility could be considered a key ﬁnding from the study, yet
this would not have been picked up on by the questionnaire alone.
4.2. Emerging themes and their relation to existing themes in this
domain
The emergent themes from the interview data both support and
further the research already carried out in this area. Similarities can
be drawnwith the themes uncovered by Lang et al. in their research
with adolescents with cystic ﬁbrosis where the theme ‘respecting
independence and capabilities’ is discussed, highlighting theadolescents’ desire to be in control (Lang et al., 2014). This rings
true with the ﬁndings here, where a main emergent theme was
‘taking control of condition’.
Whilst other research in this ﬁeld has uncovered themes largely
related to use of medical devices in social situations (O’Kane et al.,
2014; O’Kane et al., 2015) or their usability in particular settings
(Furniss et al., 2014). A key contribution of this paper is to really
bring issues surrounding data to the fore, both in terms of moni-
toring and sharing.
4.3. A holistic approach to user research for medical device design
The results from the study reinforce the need for a holistic
approach when evaluating medical devices. Whilst the data
monitoring, sharing and reminder function were viewed positively
by participants, the device’s appearance as well as the choice of
ringtones available received largely negative feedback. This high-
lights the importance of taking all aspects of design into account,
including functionality, usability and aesthetics. Sharples et al.
discuss the difﬁculties in linking medical device design with
consequent user behaviour due to the complex nature of the
context in which these devices are used (Sharples et al., 2012). It is
important we consider all aspects of design, both for the device
itself, it’s multiple user groups as well as the context it is used in, as
just one negative aspect can disrupt the entire system (Sharples
et al., 2012).
4.4. Study limitations and challenges
The ethical approval for the study required all researcher-
participant interactions to occur in a clinical environment. This
could be considered a limitation for the research, as the clinical
setting imposed time restrictions on interviews as the room was
needed for other patient appointments. Furthermore, the formal
nature of the environment may have inﬂuenced how relaxed par-
ticipants were and how freely they felt they could express their
opinions.
One effect that should be considered was having a nurse present
in the room. Although the nurse was always busy with other tasks
and was placed sufﬁciently away from the participant and
researcher to attempt to minimize any effects, there is still a pos-
sibility that their presence altered how freely participants spoke.
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must also be considered, as the young age of the participants may
have affected how openly they felt they could talk with the
researcher (Davies, 2008). However, as the researcher who con-
ducted the interviews was a young PhD student, this may have
helped to limit this effect in comparison to if a more senior
researcher had been the interviewer.
The small sample size should be considered a limitation, as
seven participants from a similar area with similar social, educa-
tional and economic backgrounds may not be representative of all
adolescents with asthma.
The small sample is partially due to recruitment challenges.
Many patients that could have been eligible to be approached were
not because they did not use the correct type of medication
(seretide or ﬂixotide). Many patients used a ‘turbohaler’ instead of a
standard metered dose inhaler. This is a ﬁnding in itself and creates
an added challenge for developers of EMDs for asthma inhalers, as a
variety of inhaler types exist and accommodating for all variations
is necessary to maximize the potential impact EMDs could have.
The addition of the themes ‘data monitoring’, ‘data sharing’ and
‘communication and feedback’ to the questionnaire could also be
considered a potential limitation as they were formed based on the
researcher’s knowledge of the SmartTrack device’s capabilities and
the structure of existing AMDAT statements. However, the overlap
between the questionnaire and interview data provides support for
their relevance in this instance.
4.5. Future research
The positive attitudes expressed by adolescents and their par-
ents for the reminder function of the device supports the ﬁndings
of a recent clinical trial where it was found that use of the Smart-
Track and its audiovisual reminder function signiﬁcantly improved
adherence in school children with poorly controlled asthma (Chan
et al., 2015). Now with evidence for the clinical effectiveness of
these reminders as well the positive attitude patients appear to
have towards them, future research is needed to further investigate
the impact that these reminders could have on asthma care. The
adolescents in this study commented on how they would like to be
able to customize the ringtones and use their own music; a future
clinical study could investigate the impact that this alteration could
have on adherence.
The questionnaire results provide support for previous research
that used the AMDAT where it was found that the category ‘Aes-
thetics’ received some of the most unfavorable responses (Lang,
2012). For the SmartTrack there was a noticeable amount of
‘strongly disagree’ responses to statements related to Aesthetics
and although this was not signiﬁcant, this may be due to device
aesthetics reportedly only being important to some adolescents
rather than all (Lang et al., 2012). Future research should look to
replicate the AMDAT method with other medical devices to
investigatewhether similar responses are received for aesthetics, as
well as for the more positive categories that were found here, such
as Data Monitoring.
Finally, this research has provided a ﬁrst step for user-
involvement in the design of EMDs for asthma. With asthma
affecting all ages and with multiple EMD designs available, there is
still a great need for continued inclusion of patients in the devel-
opment of these devices to ensure they have maximum clinical
effectiveness.
5. Conclusion
This study has provided new valuable insight into the views of
adolescents with asthma towards a device for monitoring theirinhaler use. The results have shown positive signs for these par-
ticipants being open to having their medication taking behaviour
monitored. They appear to view the prospect of sharing data with
their parents and healthcare professionals as an opportunity to
demonstrate the responsibility they have for their condition,
allowing them to experience a greater sense of independence.
The reminders that the device can provide were particularly
favored by participants and they spoke enthusiastically about the
everyday beneﬁt they could have for their condition in helping
them to remember to take their medication at times when they
otherwise would have forgotten.
The concerns participants had for the appearance of the device
and the implications it could have in social situations highlights the
importance of involving these types of users in future design and
development of devices like the SmartTrack. By using an iterative
design process with regular user feedback on issues that are
important to them, these devices can be developed to ﬁt seamlessly
into the everyday lives of patients.
This research has highlighted the beneﬁt of user involvement in
medical device design and has identiﬁed future work needed both
in asthma and other chronic conditions. Furthermore, it has rein-
forced the idea of a systems context in medical device design,
demonstrating the need to consider all aspects of a device including
data, usability and aesthetics to maximize the chances of success.
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Appendices
The statements used in the three questionnaires of the study are
provided below, categorised by the theme they fall under. State-
ments 1e5 were used in questionnaire 1, 6e10 were used in
questionnaire 2 and 11e15 were used in questionnaire 3.
Statements for the theme ‘Ease of Use’:
1. The information on the device’s screen is easy to read
2. At ﬁrst glance, the device looks confusing to use
3. I think adolescents would be able to use this device
4. I understand the purpose of the buttons on the device
5. The device looks too complicated and daunting to use
6. The information on the device’s screen is easy to understand
7. The screen on the device would beneﬁt from colour
8. The device tells me if it is not working properly or if there is
an error that needs ﬁxing
9. I think the letters and numbers on the device’s screen are
large enough
10. I could use the device
11. At ﬁrst glance, the device looks easy to use
12. This device would be usable by someone with learning
difﬁculties
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bright enough
14. I think it’s easy to learn how to use the device correctly
15. I think the buttons on the device are comfortable and easy to
press
Statements for the theme ‘Social Acceptance’:
1. I would take the device to school
2. I think this device would be appealing for teenagers to use
3. I think the device looks cool
4. I would take the device when out socially e.g. cinema,
shopping etc.
5. I think I would feel comfortable using this device out in
public
6. I’m comfortable using the device in front of very close friends
7. I’m comfortable using the device in front of other friends/
classmates
8. I would take the device to a friend’s house
9. When at home I use my device in private (e.g. in my room)
rather than in the lounge
10. I think other people think the device looks cool
11. I think other people think the device looks fun to use
12. I think adolescents would be embarrassed to use this device
13. I think adults would be embarrassed to use this device
14. My close/best friends know about my device
15. My other friends/classmates know about my device
Statements for the theme ‘Portability and Practicality’:
1. The device ﬁts comfortably in my hand
2. The device is too chunky to be held comfortably
3. The device is easy to hold e.g. shape
4. The device is easy to hold e.g. grip
5. I think this device is too big
6. The device ﬁts in my school bag
7. It would be an improvement if the device could ﬁt in a jacket
or trouser pocket
8. The device is easy to transport
9. A waterproof case for this device would encourage users to
take it out with them more often
10. I think the device would stay intact and not break if it was
dropped on the ﬂoor
11. I think the device is too heavy for it’s size
12. I think this device would beneﬁt from a protective case to
carry it around in
13. I need to sit down whilst using the device
14. The device is easy to transport
15. I think the device could easily be broken
Statements for the theme ‘Aesthetics’:
1. I like the colour of the device
2. I like the shape of the device
3. I think the device looks like it is a quality product
4. I think black is a good colour for medical devices
5. I think the device looks scary
6. The device would beneﬁt from customizable decoration
7. The device would beneﬁt from being more stylish
8. The device looks boring
9. I think the device is well designed
10. I think the device feels like it is a quality product
11. I think the device would look better in a different colour
12. I think the colour of this device is too bright and attention
grabbing13. I think the device looks unfriendly
14. I think the device looks modern
15. I think the colour of this device is too dull (and boring)
Statements for the theme ‘Data Monitoring’:
1. I feel happy with the device recording when I use my inhaler
2. Being able to track my inhaler use with the device would
help me feel in control of my condition
3. I would be interested in seeing the long-term trends of my
inhaler use available from this device
4. The device recording when I use my inhaler would make me
more likely to use it
5. The device recording when I use my inhaler would make me
less likely to use it
6. The device’s ability to record my inhaler use makes me feel
nervous or anxious
7. I would like the device to be able to link to other technolo-
gies; such as computers or mobile phones, so that I could
keep track of my routine on a non-medical based piece of
equipment
8. I like the device being able to keep track of when I use my
inhaler for me
9. I feel like the device is ‘watching’ me
10. I would like to be able to check my inhaler use when I’m at
home
11. I think I could use the device to demonstrate howwell I stick
to my inhaler treatment schedule
12. I think everyone who has Asthma should use a device like
this to keep track of their inhaler use
13. I think adolescents would feel comfortable having this device
record their inhaler use
14. If I was given the choice, I would use a device like this that
records my inhaler use, in the everyday treatment of my
asthma
15. I feel happy with the device recording my inhaler use
Statements for the theme ‘Data Sharing’:
1. I think allowing my doctor to see my inhaler use with this
device would beneﬁt my treatment and clinic visits
2. Sharing information from this device on my inhaler use with
my parents/guardians would help me show them that I’m
responsible with my asthma
3. I would want to control who could and couldn’t see infor-
mation on my inhaler use
4. I would want the data onmy inhaler use to only be accessible
to me alone
5. Having information on my inhaler use from this device
available to my asthma nurse would beneﬁt my treatment
and clinic visits
6. I like the idea of being able to see information on inhaler use
for other people at my clinic of a similar age if they were also
using this device, to compare with my own
7. I would feel happy sharing information on my inhaler use
collected by this device with my parents/guardians
8. I would feel happy sharing information on my inhaler use
collected by this device with close friends
9. I would feel happy sharing information on my inhaler use
collected by this device with my doctor
10. I would feel happy sharing information on my inhaler use
collected by this device with my nurse
11. I would feel happy sharing information on my inhaler use
collected by this device with other asthma patients
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collected by this device before deciding whether to share it
with others
13. I think having control over who can see your personal in-
formation is important
14. I think adolescents with asthma would be happy to share
information on their inhaler use
15. I think adults with asthma would be happy to share infor-
mation on their inhaler use
Statements for the theme ‘Communication & Feedback’:
1. I would like it if I could receive feedback onmy inhaler use by
text message/BBM
2. I would like it if I could receive feedback onmy inhaler use by
e-mail
3. I would like it if I could receive feedback onmy inhaler use by
phone call
4. I would like it if I could receive feedback on my inhaler use
when I visit my doctor
5. I would like it if I could receive feedback on my inhaler use
through an online website that I could login to with my own
username and password
6. I would like it if I could receive feedback onmy inhaler use in
a graph, showing over time days where I have missed doses
and days where I have taken all my doses
7. I would like it if I could receive feedback onmy inhaler use on
a daily basis
8. I would like it if I could receive feedback onmy inhaler use on
a weekly basis
9. I would like it if I could receive feedback onmy inhaler use on
a monthly basis
10. I would like it if I could receive feedback onmy inhaler use as
a simple percentage of howwell I have stuck tomy treatment
plan over a week, a month etc.
11. I would like it if I could receive feedback on my inhaler use
when I’m at home
12. I would like it if I could receive feedback on my inhaler use
when I’m at my clinic
13. I would like it if I could receive feedback on my inhaler use
when I have been sticking to my treatment plan particularly
well
14. I would like it if I could receive feedback on my inhaler use
when I have been particularly poor at sticking to my treat-
ment plan, as a reminder
15. I would like it if I could receive feedback on my inhaler use
through a Smart Inhaler smartphone appReferences
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